Fate of micelles and quantum dots in cells

被引:126
作者
Maysinger, Dusica
Lovric, Jasmina
Eisenberg, Adi
Savic, Radoslav
机构
[1] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada
[2] Univ Zagreb, Dept Pharmaceut Technol, Zagreb 41000, Croatia
[3] McGill Univ, Dept Chem, Montreal, PQ, Canada
基金
加拿大健康研究院;
关键词
block copolymer micelles; quantum dots; internalization; stability; confocal microscopy; multiple labeling; fluorescent dyes; organelles;
D O I
10.1016/j.ejpb.2006.08.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Micelles and quantum dots have been used as experimental drug delivery systems and imaging tools both in vitro and in vivo. Investigations of their fate at the subcellular level require different surface-core modifications. Among the most common modifications are those with fluorescent probes, dense-core metals or radionucleids. Cellular fate of several fluorescent probes incorporated into poly(caprolactone)-b-copolymer micelles (PCL-b-PEO) was followed by confocal microscopy, and colloidal gold incorporated in poly 4-vinyl pyridine-PEO micelles were developed to explore micelle fate by electron microscopy. More recently, we have examined quantum dots (QDs) as the next-generation-labels for cells and nanoparticulate drug carriers amenable both to confocal and electron microscopic analyses. Effects of QDs at the cellular and subcellular levels and their integrity were studied. Results from different studies suggest that size, charge and surface manipulations of QDs may play a role in their subcellular distribution. Examples of pharmacological agents incorporated into block copolymer micelles, administered or attached to QD surfaces show how the final biological outcome (e.g. cell death, proliferation or differentiation) depends on physical properties of these nanoparticles. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:270 / 281
页数:12
相关论文
共 138 条
[81]   Gold particles as templates for the synthesis of hollow polymer capsules. Control of capsule dimensions and guest encapsulation [J].
Marinakos, SM ;
Novak, JP ;
Brousseau, LC ;
House, AB ;
Edeki, EM ;
Feldhaus, JC ;
Feldheim, DL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (37) :8518-8522
[82]   Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin [J].
Matsumura, Y ;
Hamaguchi, T ;
Ura, T ;
Muro, K ;
Yamada, Y ;
Shimada, Y ;
Shirao, K ;
Okusaka, T ;
Ueno, H ;
Ikeda, M ;
Watanabe, N .
BRITISH JOURNAL OF CANCER, 2004, 91 (10) :1775-1781
[83]   Quantum dot bioconjugates for imaging, labelling and sensing [J].
Medintz, IL ;
Uyeda, HT ;
Goldman, ER ;
Mattoussi, H .
NATURE MATERIALS, 2005, 4 (06) :435-446
[84]   Imaging actin and dynamin recruitment during invagination of single clathrin-coated pits [J].
Merrifield, CJ ;
Feldman, ME ;
Wan, L ;
Almers, W .
NATURE CELL BIOLOGY, 2002, 4 (09) :691-698
[85]   Quantum dots for live cells, in vivo imaging, and diagnostics [J].
Michalet, X ;
Pinaud, FF ;
Bentolila, LA ;
Tsay, JM ;
Doose, S ;
Li, JJ ;
Sundaresan, G ;
Wu, AM ;
Gambhir, SS ;
Weiss, S .
SCIENCE, 2005, 307 (5709) :538-544
[86]   Nanomedicine: current status and future prospects [J].
Moghimi, SM ;
Hunter, AC ;
Murray, JC .
FASEB JOURNAL, 2005, 19 (03) :311-330
[87]   Oxygen free radicals and redox biology of organelles [J].
Moldovan, L ;
Moldovan, NI .
HISTOCHEMISTRY AND CELL BIOLOGY, 2004, 122 (04) :395-412
[88]   ALTERATION OF INTRACELLULAR TRAFFIC BY MONENSIN - MECHANISM, SPECIFICITY AND RELATIONSHIP TO TOXICITY [J].
MOLLENHAUER, HH ;
MORRE, DJ ;
ROWE, LD .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1031 (02) :225-246
[89]   EEA1, AN EARLY ENDOSOME-ASSOCIATED PROTEIN - EEA1 IS A CONSERVED ALPHA-HELICAL PERIPHERAL MEMBRANE-PROTEIN FLANKED BY CYSTEINE FINGERS AND CONTAINS A CALMODULIN-BINDING IQ MOTIF [J].
MU, FT ;
CALLAGHAN, JM ;
STEELEMORTIMER, O ;
STENMARK, H ;
PARTON, RG ;
CAMPBELL, PL ;
MCCLUSKEY, J ;
YEO, JP ;
TOCK, EPC ;
TOH, BH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) :13503-13511
[90]   Endocytosis [J].
Mukherjee, S ;
Ghosh, RN ;
Maxfield, FR .
PHYSIOLOGICAL REVIEWS, 1997, 77 (03) :759-803